493 related articles for article (PubMed ID: 6440727)
21. A sensitive ELISA for von Willebrand factor (vWf:Ag).
Ingerslev J
Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic problems of von Willebrand's disease in a general hospital laboratory.
Dahl CJ; McRoyan DK; Liu PI
Ann Clin Lab Sci; 1983; 13(5):371-8. PubMed ID: 6416137
[TBL] [Abstract][Full Text] [Related]
23. Clinical observations and their relationship to laboratory findings in the haemophilias.
Rainsford SG; Hall A
Thromb Diath Haemorrh; 1975 Dec; 34(3):734-9. PubMed ID: 1082180
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of sugar composition of factor VIII/von Willebrand factor in von Willebrand's disease: analysis by crossed affinoimmunoelectrophoresis using lectin (ricinus communis agglutinin-120).
Mikami S; Ueda M; Yasui M; Takahashi Y; Nishino M; Fukui H
Thromb Haemost; 1983 Apr; 49(2):87-90. PubMed ID: 6408753
[TBL] [Abstract][Full Text] [Related]
25. Variant forms of von Willebrand's disease.
Koie K; Kamiya T; Ogata K; Takamatsu J
Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):872-82. PubMed ID: 121662
[No Abstract] [Full Text] [Related]
26. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
[No Abstract] [Full Text] [Related]
27. Pseudo-von Willebrand's disease.
Hoyer LW
N Engl J Med; 1982 Feb; 306(6):360-2. PubMed ID: 6798443
[No Abstract] [Full Text] [Related]
28. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease.
Holmbeg L; Nilsson IM
Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718
[TBL] [Abstract][Full Text] [Related]
29. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
[TBL] [Abstract][Full Text] [Related]
30. Study of congenital VIII complex deficiency syndrome: use of enzyme conjugated antibody.
Han P; Teo SH; Wong HB
J Singapore Paediatr Soc; 1987; 29(1):44-7. PubMed ID: 3121916
[No Abstract] [Full Text] [Related]
31. [Diagnosis of von Willebrand's disease subtypes by the analysis of multimeric composition of plasma von Willebrand factor].
Quiroga T; Pérez M; Pereira J; Mezzano D
Rev Med Chil; 1993 Sep; 121(9):987-93. PubMed ID: 8191164
[TBL] [Abstract][Full Text] [Related]
32. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII.
Thomas JE; Peake IR; Giddings JC; Welch AN; Bloom AL
Thromb Haemost; 1985 Feb; 53(1):143-7. PubMed ID: 3922077
[TBL] [Abstract][Full Text] [Related]
33. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
[TBL] [Abstract][Full Text] [Related]
34. Application of immunological techniques to the study of classic haemophilia and von Willebrand's disease.
Bennett B
Br J Haematol; 1973 Aug; 25(2):273-4. PubMed ID: 4580214
[No Abstract] [Full Text] [Related]
35. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
[No Abstract] [Full Text] [Related]
36. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
37. [Application if different techniques to the diagnosis of von Willebrand's disease (author's transl)].
Solana JM; Rocha E; Arrizabalaga B; López A; Febres R; Fernández J
Sangre (Barc); 1981; 26(6):1156-63. PubMed ID: 6805084
[No Abstract] [Full Text] [Related]
38. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of factor VIII/von Willebrand's factor concentrate (Haemate-P) in preventing bleeding during surgery or invasive procedures in patients with von Willebrand disease.
Franchini M; Rossetti G; Tagliaferri A; Pattacini C; Pozzoli D; Lippi G; Manzato F; Bertuzzo D; Gandini G
Haematologica; 2003 Nov; 88(11):1279-83. PubMed ID: 14607757
[TBL] [Abstract][Full Text] [Related]
40. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
Brinkhous KM
Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
